NDRG2 expression was deficient in many kinds of tumors, such as melanoma, glioblastoma, thyroid cancer, colon cancer, and pancreatic cancer [18, 19], and NDRG2 was able to inhibit proliferation of certain tumor cells [20–22]. This evidence concerns the gene NDRG2 and familial pancreatic carcinoma.